ABOUT EVENT

The Annual European Industry Touchpoint to Co-Develop
Drug-Diagnostics

Key Stats - Clinical Biomarkers & CDx Europe

As recent advances in small molecules, ADCs, cell, and gene therapies poise novel precision therapies from the bench to the clinic, the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe returns with 3 days of data-driven case studies and strategic insights to address your most prevalent pain points.

Join Your Peers To:

Bolster Biomarker Discovery & Validation

Be the first to hear the latest advances in biomarker discovery and validation in oncology, cardiovascular, metabolic, autoimmune and rare diseases to improve patient selection and monitoring

Implement Novel Technologies & Trials

Witness the surge in liquid biopsy and genomic innovations with insights spanning ctDNA translation to sequencing commercialisation to bolster improved cancer diagnosis and monitoring

Pioneer Digital &
AI-Enabled Innovations

Discover the latest digital innovations from multi-omics to computational pathology for more scalable and physician appropriate interventions

Optimise
Drug-Diagnostic
Co-Development

Explore the initiation, scale-up and regulatory responsibilities of co-development partnerships to spark compliant and scalable strategic alliances for accelerated approvals

Streamline CDx Development & Commercialisation

Get updated on the launch planning and commercialisation pathways poising access to the European market in 2025 across oncology and non-oncology indications

Navigate
IVDR-Adherence

Cast your attention to the expectations of notified bodies and regulators across Europe to streamline IVDR compliance and stay alert in the face of country-specific filing nuances

What Your Peers Have to Say:

quotation marks left

Amazing quality of speakers, underpinned by representation of different stakeholders from Pharma, IVD manufacturers and Notified Bodies, leading to valuable networking sessions.

- Past Attendee, Director

quotation marks right
Logo_Pierre_Fabre
quotation marks left

Great content, great networking opportunity and phenomenal industry experts!

- Past Event Partner, Marketing Manager

quotation marks right
Roche_Logo.svg
quotation marks left

Interesting breadth of talks and panel discussions, accompanied by meaningful interactions with potential CDx company partners.

- Past Attendee, Director, Clinical Biomarkers

quotation marks right
ipsen